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Livestock Models in Translational Medicine
Abstract
This issue of the ILAR Journal focuses on livestock models in translational medicine. Livestock models of
selected human diseases present important advantages as compared with rodent models for translating
fundamental breakthroughs in biology to useful preventatives and therapeutics for humans. Livestock reflect
the complexity of applying medical advances in an outbred species. In many cases, the pathogenesis of
infectious, metabolic, genetic, and neoplastic diseases in livestock species more closely resembles that in
humans than does the pathogenesis of rodent models. Livestock models also provide the advantage of similar
organ size and function and the ability to serially sample an animal throughout the study period. Research
using livestock models for human disease often benefits not only human health but animal health and food
production as well. This issue of the ILAR Journal presents information on translational research using
livestock models in two broad areas: microbiology and infectious disease (transmissible spongiform
encephalopathies, mycobacterial infections, influenza A virus infection, vaccine development and testing, the
human microbiota) and metabolic, neoplastic, and genetic disorders (stem cell therapy, male germ line cell
biology, pulmonary adenocarcinoma, muscular dystrophy, wound healing). In addition, there is a manuscript
devoted to Institutional Animal Care and Use Committees’ responsibilities for reviewing research using
livestock models. Conducting translational research using livestock models requires special facilities and
researchers with expertise in livestock. There are many institutions in the world with experienced researchers
and facilities designed for livestock research; primarily associated with colleges of agriculture and veterinary
medicine or government laboratories.
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Abstract
This issue of the ILAR Journal focuses on livestock models in translational medicine. Livestock models of selected human
diseases present important advantages as comparedwith rodentmodels for translating fundamental breakthroughs in biology
to useful preventatives and therapeutics for humans. Livestock reﬂect the complexity of applying medical advances in an
outbred species. In many cases, the pathogenesis of infectious, metabolic, genetic, and neoplastic diseases in livestock species
more closely resembles that in humans than does the pathogenesis of rodent models. Livestock models also provide the
advantage of similar organ size and function and the ability to serially sample an animal throughout the study period. Research
using livestockmodels for human disease often beneﬁts not only human health but animal health and food production aswell.
This issue of the ILAR Journal presents information on translational research using livestock models in two broad areas:
microbiology and infectious disease (transmissible spongiform encephalopathies, mycobacterial infections, inﬂuenza A virus
infection, vaccine development and testing, the humanmicrobiota) andmetabolic, neoplastic, and genetic disorders (stem cell
therapy, male germ line cell biology, pulmonary adenocarcinoma, muscular dystrophy, wound healing). In addition, there is a
manuscript devoted to Institutional Animal Care and Use Committees’ responsibilities for reviewing research using livestock
models. Conducting translational research using livestock models requires special facilities and researchers with expertise in
livestock. There are many institutions in the world with experienced researchers and facilities designed for livestock research;
primarily associated with colleges of agriculture and veterinary medicine or government laboratories.
Key words: cattle; genetic diseases; genomics; infectious diseases; metabolic diseases; sheep; swine; translational medical
research
This issue of the ILAR Journal focuses on livestock models for
human diseases. It builds upon a previous issue on “Naturally
occurring diseases in animals: contributions to translational
medicine” (Lairmore and Khanna 2014). Inbred rodents have
been very important models for research to understand funda-
mental mammalian biology and disease processes. The ability
to use syngeneic mice and to manipulate their genetic traits
has produced major advances that underpin modern medicine.
However, small groups of inbred rodents should not be expected
to mimic the complexity of genetically heterogeneous human
populations. Nonhuman primates have been powerful models
for translational studies for human application, however, their
availability is limited and there are many ethical questions
surrounding their acquisition and use.
Livestock models of selected human disease present
important advantages as compared with rodent models when
it comes to translating fundamental breakthroughs in biology
to useful preventatives and therapeutics for humans. Livestock
reﬂect the complexity of applying medical advances in an out-
bred species. In many cases the pathogenesis of infectious, met-
abolic, genetic, and neoplastic diseases in livestock species more
closely resembles that in humans than does the pathogenesis of
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rodent models. Livestock models also provide the advantage of
similar organ size and function and the ability to serially sample
an animal throughout the study period.
A dramatic improvement in our understanding of human bi-
ology beganwith completion of the sequencing of the human ge-
nome (International Human Genome Sequencing Consortium
2004). The original primary goal of the human genome project,
providing tools and resources to identify genes and variants
causing monogenic human disease, has been completed, and
ﬁnding a gene variant causing a genetically simple disease is
now trivial given access to patients and controls. Further, many
examples of gene variants associated with complex diseases
also have been reported. Interestingly, excellent examples of
such identiﬁcations often arise from analysis of domesticated
animal populations that have well-documented phenotypic
records (Andersson 2013). This enlightenment of the genotype–
phenotype association has accelerated with the functional de-
coding of many DNA elements (ENCODE Project Consortium
2012) in the human genome, although such information is
scant for livestock species. A recent initiative is focused on im-
proving this situation: the recently announced Functional Anno-
tation of ANimal Genomes (FAANG) project (FAANG Consortium
2015) proposes to create ENCODE-type data for those domesticat-
ed species with a well-developed genome assembly. Coupled
with the already available phenotypic resources on these species,
the complex relationship between natural genotypic and pheno-
typic variation could be explored at unprecedented scales. Such
data will further establish these species as models for human
disease, as well as develop valuable practical information for ag-
riculture. In addition, with the rapid technical advances in preci-
sion genome editing (Cox et al. 2015), it is now possible to quickly
and speciﬁcallymodify any gene in the genome. Inmany cases, it
is possible to predict the effect of such mutations on phenotype
based on a detailed understanding of the expression patterns of
the gene and the predicted function of its product; deep annota-
tion of genome component function will expand this capability.
As depicted in several papers in this special issue, the creation of
a model often involves a genetic manipulation to mimic the de-
fect in patients. Such manipulations require molecular genetic
information, and often a detailed understanding of the physio-
logical and molecular pathways involved. The last 10 years
have seen an explosion of such genomic information on a
range of vertebrates, several of which have served as models in
translational medicine. These genome sequences provide an op-
portunity for more systematic and detailed modeling at multiple
levels: molecular, cellular, metabolic, and organismal (Tuggle
et al. 2011). Such modeling depth will be a necessary component
of any models in the future, as data-driven analysis of human
systems continues to expand (Carter et al. 2013). Thus the ﬂedg-
ling FAANG project, which aims to create for domesticated spe-
cies deep functional information similar to that currently
available for humans, will add substantially to the value of
these species as translational models.
Pigs have proven to be an especially importantmodel in trans-
lational research, particularly in medical device development,
xenotransplantation, and therapeutics due to the similar size,
anatomy, and physiology of human and pig organs (Judge et al.
2014). The ability to produce transgenic pigs with selected
human genes enhances their potential to serve as organ donors
(Ibrahim et al. 2006). The similarities of the innate (Fairbairn et al.
2011; Kim et al. 2014) and adaptive (Butler et al. 2009) immune
systems of pigs and humans has led to the use of pigs as transla-
tional models for the study of various infectious diseases and in
vaccine development (Meurens et al. 2012). A recent sequence-
level comparison of human and porcine genes involved in immu-
nity demonstrates their close similarity (Dawson et al. 2013).
Transgenic pig models have been established for neurodegener-
ative diseases, cardiovascular diseases, and diabetes mellitus
(Aigner et al. 2010). Genetically modiﬁed porcinemodels of cystic
ﬁbrosis have been generated that develop lung disease similar to
human cystic ﬁbrosis (Rogers et al. 2008), an important deﬁciency
of mouse models (Judge et al. 2014). Pigs are also increasingly
being considered as the model of choice for preclinical toxicologic
testing of pharmaceuticals (Swindle et al. 2012).
Livestock Translational Models in
Microbiology and Infectious Disease
In this issue, examples are presented of basic research in live-
stock translating into improved prevention and therapeutics
not only for humans but also for the livestock species. Many in-
fectious diseases have co-evolved in livestock andhumans due to
their close interaction for thousands of years. This similarity al-
lows the study of early pathogenesis and interventions in the
livestock model. For important zoonotic diseases such as bovine
tuberculosis, swine inﬂuenza, bovine spongiform encephalopa-
thy, brucellosis, leptospirosis and many others, the livestock
species may serve as the reservoir host, or amplifying host.
Therefore, research on these naturally occurring diseases not
only leads to important advances in translational medicine, but
also leads to improved detection and prevention in livestock
reducing exposure of humans and contributing major beneﬁts
to public health (Roth 2011).
Transmissible spongiform encephalopathies (TSEs) are an ex-
cellent example of research in livestock having multiple beneﬁts
for livestock health, food production, and public health as well as
translational research as amodel for TSEs in humans. Drs. Justin
and M. Heather Greenlee summarize research advances in two
TSEs of livestock: bovine spongiform encephalopathy (BSE) in
cattle and scrapie in sheep and goats. Basic research on BSE
and scrapie has made major contributions to the understanding
of the biology and pathogenesis of prions. All TSEs share patho-
logic features and infectious mechanisms, but have distinct
differences in transmission and epidemiology. TSEs can be ac-
quired through exposure to infectious materials, but inherited
and spontaneous TSEs also occur. BSE can be transmitted to peo-
ple through ingestion of infectious material and can cause vari-
ant Creutzfeldt-Jakob disease. Research on BSE was essential to
break the transmission cycle between cattle and to people.
Mycobacterium bovis is a zoonotic infectious agent of livestock
and wildlife, which can produce severe disease in people. There
is a long history of mutually beneﬁcial research leading to im-
proved understanding of tuberculosis in both livestock and peo-
ple. Drs. Waters and Palmer summarize advances in detection
and control of human tuberculosis resulting from livestock and
wildlife research on M. bovis and discuss advances in under-
standing the pathology and immunology of M. bovis infection
based on advances in M. tuberculosis research. Advances in
diagnostic testing and vaccines for prevention of tuberculosis
in people have been tested with M. bovis infection in cattle and
reﬁned before translated for use in people. Recent advances in
understanding the immunology of mycobacterial infections are
summarized in this review and current efforts to develop safer
and more effective vaccines using the M. bovis model are
discussed.
Rajao and Vincent make a compelling case for the use of
swine as a model for inﬂuenza A virus (IAV) infection and
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immunity in people. The same subtypes of IAV are endemic in
both species and there has been repeated exchange of viruses be-
tween these two hosts. There is a similar distribution of IAV re-
ceptors in the respiratory tract, and the clinical manifestation
and pathogenesis are similar. The ability to control maternal an-
tibody transfer to newborn pigs through ingestion of colostrum
enables experimental designs with groups receiving nomaternal
antibodies or maternal antibodies with deﬁned antibody titer
and speciﬁcity. This is a powerful tool for elucidating the role of
passive antibody in immunity, in interference with vaccine re-
sponses, and in enhancement of respiratory disease. The swine
model has convincingly demonstrated the beneﬁts of modiﬁed
live intranasal vaccines for inducing heterosubtypic immunity
and allowed the investigation of immunemechanisms responsi-
ble. It has also allowed the discovery and characterization of vac-
cine-associated enhanced respiratory disease (VAERD) when
inactivated vaccines are used that are not closely matched to
the hemagglutinin protein of the challenge strain of virus.
There is still more to be learned about the pathogenesis and
immunology of inﬂuenza in people. The swine model is an im-
portant tool for understanding mechanisms of virulence and
protective immunity, and for developing more efﬁcacious
vaccines and other forms of prevention and treatment.
Gerdts and colleagues discuss efforts to reduce and replace
the need for animals in human vaccine research and regulatory
approval; however, some use of animal models for development
and regulatory approval of human vaccines is essential to mimic
the complexities of the immune response. They make the case
that no single animalmodel provides all of the information need-
ed for advancing a novel vaccine through the preclinical phase of
development and that large animal models are often better than
rodent models for predicting vaccine outcomes in humans. They
review advantages and disadvantages of selected livestock mod-
els of infectious diseases that have proven to be valuable for pre-
clinical evaluation of vaccines for human disease. Advances in
reagent availability for characterizing the immune response of
livestock are improving the ability to use livestock models for
human vaccine evaluation.
There is growing recognition of the important role of the gut
microbiota in maintaining health and in disease pathogenesis.
Donovan and colleagues review the use of human microbiota-
associated (HMA) swine in translational research. The high
degree of similarity in anatomy, physiology, immunology, and
brain growth between swine and humans make pigs a better
model than rodents for studying the inﬂuence of the microbiota
on human gastrointestinal, immune, and brain development.
HMA piglets have been established using inocula from infants,
children, and adults. Importantly, Biﬁdobacterium spp. and Bacter-
oides spp., predominant bacterial groups of the infant gut, have
been established in the HMA piglets. The HMA pig model may
be valuable for investigating how the gutmicrobiota composition
changes in response to environmental factors, such as age, diet,
antibiotic use, and infection. The HMA pig also promises to be a
useful model for screening the efﬁcacy of pre- and probiotic
interventions and for elucidating microbe–host interactions in
health and disease.
Livestock Translational Models for Metabolic,
Neoplastic and Genetic Disorders
Both technologies and developed models for speciﬁc metabolic,
neoplastic, and genetic disease are also described in this issue.
These include the development of technology to test induced
pluripotent stem cells (iPSC) and spermatogonial stem cells
(SSC), as well as models for studying lung cancer, muscular
dystrophy, and wound healing.
Models for preclinical testing of stem cell therapeutics are
described by Michael Roberts and colleagues, with a focus on
the use of pigs in development and testing of iPSC. The authors
detail a need for pig models to test three necessary aspects of
iPSC-based therapy:
• safety: iPSC can form teratomas or carcinomas if cells are not
differentiated;
• efﬁcacy: iPSC can function to cure or alleviate disease symp-
toms; and
• stability: as the transferred iPSC can be rejected by the host.
Large-animal models are highlighted, as the current success of
translation of preclinical results past Phase II trials is less than
20% (Arrowsmith and Miller 2013). The authors point out that
the principle of homology to humans is important in selecting
a model, and that while the mouse as an animal model has eco-
nomic and infrastructural advantages, new technology for genet-
ic modiﬁcation may increase availability of useful large animal
models with higher biological homology to humans. A lack of re-
search data on a range of practical questions on development of
such models will continue to slow progress, however.
Roberts and colleagues provide a history of research on plu-
ripotent stem cells from livestock species, culminating in partial-
ly successful reports on creating iPSC. Currently there is no clear
demonstration that iPSC can contribute to the germ line, likely
due to incomplete reprogramming of the iPSC. However, they
also discuss parallel studies on recent work showing human
iPSC transplantation into pigs. For example, there is a growing
bodyof data that pigsmay be useful preclinicalmodels for testing
heart muscle repair protocols using human iPSC-derived cardio-
myocytes. While some early mutations have been achieved that
document the value of the pig model in testing safety and efﬁca-
cy, more work lies ahead before cures are achieved. New ap-
proaches to creating hosts that are tolerant to xenogenic iPSC
are also described. Severe combined immunodeﬁcient (SCID)
pig lines have been described that are tolerant because they are
severely deﬁcient in adaptive immunity. SCID pigs have been cre-
ated by mutagenesis or by identiﬁcation of natural mutations.
Speciﬁcally, the Roberts group has reported that pigs with muta-
tions in RAG2 were tolerant of human iPSC; however, the trans-
ferred cells formed teratomas in the recipients. The authors
also discuss interesting possibilities in the use of stem cells in xe-
notransplantation, outlining creation of chimeric pigs with a
pancreas formed exclusively from differentiated human pluripo-
tent donor cells as a source of human stem cell-derived organs
for transplant. They also discuss the technologies available, as
well as those still needed, for in vitro production of meat from
myogenic derivatives of iPSC.
The study of male gametogenesis and its relationship to
translational medicine is summarized by Gonzalez and Dobrin-
ski. A description of the utility of collecting sperm for conserva-
tion of endangered or valuable germplasm is followed by a
summary of methods for the study of spermatogenesis, with de-
tailed information on gene cell (GC) isolation and analysis. A crit-
ical area of study is identifying genemarkers for undifferentiated
and potentially self-renewing stem cells. Several candidate
markers have been proposed for several species, including cattle,
dog, horse, pig, goat, and sheep. In parallel with these molecular
studies, transfer of GC and successful production of offspring de-
rived from transferred GC has been reported for mice and several
large-animal species. The efﬁciency of these procedures is still
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low, and attempts to both improve purity of theGC preparation as
well as modify the recipient environment to increase success
rates are described. The authors point out the striking differences
in immunotolerance between mouse and large-animal species,
where unmatched donor and recipient GC transfer can be suc-
cessful only in the latter. The authors complete their review by
providing examples of the practical uses of spermatogonial
stem cells (SSC), which includes the study of spermatogenesis
itself, and the preservation of unique lines of animals formainte-
nance of biodiversity or storing superior genetics. They comment
in detail on the use of SSC in generating transgenic animals,
where SSC have some advantages over othermethods in rapidity
in passing on transgenes from males to offspring. While long-
term culture of SSC has not been achieved in large animals,
rapid mutagenesis techniques may overcome these roadblocks.
Lung cancer is the most common human cancer worldwide,
and while the environmental insult of tobacco smoke is clearly
a major factor in the incidence of such cancers, Youssef and
colleagues discuss the fact that the incidence of lung cancers is
increasing among nonsmokers. Interestingly, tumors from
smokers and nonsmokers have distinct features, including
diverse causal genetic mutations. After summarizing types of
animal models for lung cancers, the authors focus on the ovine
pulmonary adenocarcinoma (OPA) model in sheep. Although
OPA is caused by infection with a speciﬁc virus, jaagsiekte
sheep retrovirus (JSRV), the resulting cancer phenotype is quite
similar to human bronchioloalveolar cancer, which is a form of
non-small cell lung cancer in humans. The authors recount the
common signaling pathways affected in human adenocarcino-
mas and OPA, including the PI3K-Akt-mTOR and RAF-MEK-
ERK1/2 pathways, and then describe lines of evidence that
document similarities at the gene response and cellular levels be-
tween human cancers and the OPAmodel. Several experimental
platforms are used in the OPA model, including an in vivo lamb
disease model. This model has strengths including the ability
to precisely control tumor development through JSRV infection
of very young lambs at speciﬁc times and lung regions and the
possibility of using different viral genotypes as an infectious
clone of JSRV. In addition, the lamb model enables the study of
early stages of tumor progression, which is very difﬁcult to iden-
tify in human patients, who are usually in late stages of the dis-
ease when it is diagnosed. Current limitations include the
inability to titer virus accurately, as permissive cell lines are not
available to grow JSRV. The authors also discuss an in vivo cancer
model in mice where infection with adeno-associated virus ex-
pressing the tumor-causing Env protein of JSRV can model ade-
nocarcinoma as well; responses observed in the lamb infected
with JSRV are similar to those seen in this infection in mice.
Beyond the early diseasemodel, naturally infected older animals
can also be identiﬁed and studied to gain insight into latter stages
of the disease. The authors also provide an early glimpse into
new in vitro models using lung tissue slices, which can be infect-
ed with JSRV and maintained for 3–4 weeks in culture to study
early events in a model that bridges the in vivo lamb model and
late-stage natural infections. Response to infection in the lung
tissue slicemodel includes activation of the Akt and ERK1/2 path-
ways, and shows the model appears to reﬂect in vivo responses.
The authors conclude by posing the question as to the cause of
human cancers in nonsmokers: could there be a viral cause?
They recount that while there is no epidemiological evidence of
transmission of JSRV-related adenocarcinomas to people in
close proximity to infected sheep, JSRV can infect human cells
in vitro, and antibodies to JSRV proteins are reactive to an un-
known epitope in human cancer tissues. Thus, while veriﬁcation
of a possible viral etiology in human lung adenocarcinomas
awaits more deﬁnitive analyses, the experimental OPA model
in lambs is established for studying early events in development
of these lung cancers.
Selsby and colleagues provide a summary of the devastating
effects of Duchenne muscular dystrophy (DMD), which is caused
bymutations on the dystrophin gene. Dystrophin encodes a large
protein that is critical for transfer of actin-myosin contractile
force from muscle to the skeleton. The lack of functional dystro-
phin causes a loss of calcium homeostasis, inﬂammation and
eventual protein degradation and muscle loss. The authors also
describe Becker muscular dystrophy (BMD), which is a less severe
form of the disease caused by inadequate dystrophin function.
They argue that therapies for DMD that currently show promise
in animal trials are likely to be partially effective, predicting that
patients so treatedwould exhibit a BMDphenotype, and thus pre-
clinical models for both DMD and BMD are needed. The authors
then describe advantages and disadvantages of the mouse mdx
model, amainstayof dystrophy research; the golden retriever, hy-
pertrophic feline, and Zebraﬁshmodels; and twonewly generated
rat models. They then turn to their central topic, the creation and
development of porcine dystrophymodels, ﬁrst providing general
advantages of the porcine species as a model, focusing on the
high similarity of pig and human hearts, as cardiomyopathy is a
component of dystrophy and a growing cause of death in muscu-
lar dystrophy patients. A description of several genetically modi-
ﬁed porcine models is provided, including published and
unpublished lines of pigs that reportedly can mimic signiﬁcant
aspects of the DMD phenotype. In addition, the authors describe
a spontaneous porcine dystrophinopathy model, which through
genetic analysis was shown to be due to a novel nonsynonymous
mutation (R1958W) in the dystrophin gene. The phenotype is one
of 70% decreased dystrophin expression inmuscles. Affected pigs
show skeletal muscle necrosis at 2 months of age, and foci of ne-
crosis in heart tissue at 12 months of age. Abnormalities in the
electrocardiogram were also observed in these pigs. The authors
also discuss future analyses on respiratory and cardiac function
in this promising BMD-like model of dystrophin insufﬁciency.
The healing of skin wounds is universally important in
human and veterinary medicine. Seaton and colleagues discuss
the use of the porcinemodel for the study of skin wound healing.
The authors identify anatomical, structural, and physiological as
well as protein distributional similarities between human and
pig skin. While some differences exist, a comparison of multiple
studies found that porcine skin is most concordant with human
compared with several other models, which are no better than
concordance of in vitro studies to humans (Sullivan et al. 2001).
Seaton and colleagues discuss the different metrics to assess
wound healing, as well as the methods to create speciﬁc types
of injuries and emphasize that the depth of thewound is a critical
factor in type and success in healing. A major category is chronic
nonhealing wounds, which are caused by a number of factors. Of
these, an important factor is diabetes, as this is increasing in
prevalence in theUnited States and thus is an increasing problem
in the healing of wounds. A pig model of diabetic wound healing
processes using streptozotocin treatment has been developed.
Several groups have used this model to investigate blood and
growth factor secretion characteristics, aswell as cell-based ther-
apeutics and the effect of concomitant burns or bacterial infec-
tion on the rate and type of wound healing. The authors also
discuss additional burn wound models, including sepsis as a
complication, and the effects of debriding wounds and timing
of treatments such as skin engraftments. Inmany of these exper-
imental approaches, the pig model provides insights that could
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allow more focused clinical trials. One wound healing defect
highlighted is hypertrophic scarring, in which excessive colla-
gen-based ﬁbroproliferation increases the size of and pain asso-
ciated with the resulting scar. A Red Duroc model has been
developed by the authors, and has been shown to be an appropri-
ate model for humans with hypertrophic scars. Comparisons of
the RedDuroc pigwith theYorkshire pig, a nonhypertrophic scar-
ring breed, has showndifferent patterns of growth factors and ex-
pression of collagen and MMP2, TIMP and other genes in skin. It
was shown that these phenotypes have a genetic basis, as they
were intermediate in offspring of the Duroc × Yorkshire cross. Be-
cause of the structural similarity of human and pig skin, the pig
has also been used to test products designed to improve wound
healing. While the costs and complications of working with
such large-animal models are recognized, the authors conclude
that these models have provided increased understanding of
the molecular events during wound healing and further model
development is justiﬁed.
Welfare and Ethical Considerations
An area of growing concern is the ethical and welfare consider-
ations of using animal models in translational research. There
is a concerted effort to reduce, replace and reﬁne the use of
animal models. For example, there has been some success in
reducing the use of animals for potency and safety testing of
both human and veterinary vaccines (Isbrucker et al. 2011;
Kulpa-Eddy et al. 2011; McFarland et al. 2011). Animal welfare is
a concern anytime that animals are used in research, especially
whenever the research protocol leads to pain, physical discom-
fort, or mental distress. Livestock have been domesticated and
are therefore more accustomed to contact with humans and to
some levels of conﬁnement as compared with primates or wild
animals. Humane use and welfare are high-priority concerns
when using any animals in research. This is addressed in the
manuscript on “IACUC considerations on livestock models in
translational medicine” by Thulin and Underwood. As men-
tioned above, the translational research often also beneﬁts the
livestock species, which partially addresses the ethical concerns.
Conclusions
In spite of the advantages discussed in the papers in this special
issue, livestock models have been underutilized in translational
research. This has been partially due to the slow realization of
their advantages and value and to the perceived expense and dif-
ﬁculty of using livestock models. The use of livestock models is
not difﬁcult for institutions with appropriate facilities and inves-
tigators with experience in livestock research. There are many
such institutions in theworld, primarily associated with colleges
of agriculture and veterinary medicine or government laborato-
ries. These institutions have typically focused on research for
the beneﬁt of livestock health, food safety, and food production.
These institutions and investigators have the capability to
be more engaged in translational research for the beneﬁt of
human health. The increased cost of livestock models as com-
pared to rodent models needs to be weighed against the added
value they may provide in translational research.
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